Course Description
-
1:15-1:30 PM: Ian McGrane, PharmD, BCPP, Associate Professor, The University of Montana Skaggs School of Pharmacy; Providence St. Patrick Hospital, Missoula, MT
Successful Electroconvulsive Therapy After Failed Pharmacotherapies in an Older Female on Hemodialysis with Bipolar Mania
Innovative Practices Award:
-
1:30-1:45 PM: Haley Pals, PharmD, Substance Use Disorder/Psychiatric Clinical Pharmacist, Tomah VA Medical Center, Tomah, WI
Optimizing the Role of the Clinical Pharmacist Practitioner in Collaborative Buprenorphine Management to Improve Rural Access - 1:45-2:00 PM: Carolanne Wartman, PharmD, BCPS, Resident, Eskenazi Health, Indianapolis, IN
Original Research Award
-
2:00-2:15 PM: Christie Costello, PharmD, BCPS, PGY2 Psychiatry Pharmacy Resident, Medical University of South Carolina, Charleston, SC
Utilization Of Droperidol Versus Haloperidol For Acute Agitation In Psychiatric Patients Within The Emergency Department -
2:15-2:30 PM: Carolyn O’Donnell, PharmD, PGY2 Psychiatric Pharmacy Resident, University at Buffalo / New York State Office of Mental Health at the Buffalo Psychiatric Center, Williamsville, NY
Determining the Impact of High-Density Lipoprotein Cholesterol Levels and their Influence on Movement Disorders in Patients Taking Antipsychotics
Research Trainee Award
-
2:45-3:00 PM: Casey Tiefenthaler, PharmD, PGY2 Psychiatry Resident, UC San Diego Health, San Diego, CA
Antidepressant Prescribing Patterns in Transgender Individuals Diagnosed with Gender Dysphoria and Mood or Anxiety Disorders -
3:00-3:15 PM: Brittany Weger, Student, High Point University, North Carolina, NC
Practical Approaches to Antidepressant-Associated QTc Prolongation: A Review of Cases
CPNP Foundation Strategic Goals Award
- 3:15-3:30 PM: Kathryn Comanici, PharmD, Regulatory Pharmaceutical Fellow in Drug Information, Purdue University, FDA, and Eli Lilly and Company, Indianapolis, IN
-
3:30-3:45 PM: Logan Smith, Student, University of Georgia College of Pharmacy, Athens, GA
Prevalence of Impostor Phenomenon Among Graduate Students in Pharmacy and Counseling Psychology
Target Audience
If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.
Faculty
View biographical information
Ian McGrane, PharmD, BCPP, Associate Professor, The University of Montana Skaggs School of Pharmacy; Providence St. Patrick Hospital, Missoula, MT
Haley Pals, PharmD, Substance Use Disorder/Psychiatric Clinical Pharmacist, Tomah VA Medical Center, Tomah, WI
Carolanne Wartman, PharmD, BCPS, Resident, Eskenazi Health, Indianapolis, IN
Christie Costello, PharmD, BCPS, PGY2 Psychiatry Pharmacy Resident, Medical University of South Carolina, Charleston, SC
Carolyn O’Donnell, PharmD, PGY2 Psychiatric Pharmacy Resident, University at Buffalo / New York State Office of Mental Health at the Buffalo Psychiatric Center, Williamsville, NY
Casey Tiefenthaler, PharmD, PGY2 Psychiatry Resident, UC San Diego Health, San Diego, CA
Brittany Weger, Student, High Point University, North Carolina, NC
Kathryn Comanici, PharmD, Regulatory Pharmaceutical Fellow in Drug Information, Purdue University, FDA, and Eli Lilly and Company, Indianapolis, IN
Logan Smith, Student, University of Georgia College of Pharmacy, Athens, GA
Course Requirements
To receive ACPE credit for this session, you must:
- Register for this course.
- Review the full content of the activity and reflect upon its teachings.
- Complete the evaluation at the end of the activity.
- Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Continuing Education Credit and Disclosures
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
View disclaimer and disclosure of off-label use
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
View fair balance and integrity statement
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.